LeMaitre Vascular Inc (LMAT)
Operating profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 36,712 | 33,473 | 30,443 | 26,775 | 26,829 | 28,163 | 31,086 | 36,408 | 36,425 | 37,669 | 38,614 | 32,380 | 28,788 | 24,171 | 20,058 | 21,101 | 21,183 | 23,448 | 22,156 | 27,782 |
Revenue (ttm) | US$ in thousands | 289,940 | 282,011 | 312,579 | 295,977 | 281,639 | 280,188 | 278,441 | 275,316 | 267,547 | 265,592 | 262,196 | 231,031 | 220,642 | 213,264 | 198,609 | 208,001 | 203,956 | 202,175 | 168,273 | 142,095 |
Operating profit margin | 12.66% | 11.87% | 9.74% | 9.05% | 9.53% | 10.05% | 11.16% | 13.22% | 13.61% | 14.18% | 14.73% | 14.02% | 13.05% | 11.33% | 10.10% | 10.14% | 10.39% | 11.60% | 13.17% | 19.55% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $36,712K ÷ $289,940K
= 12.66%
The operating profit margin of Lemaitre Vascular Inc has shown a gradual decline over the past four quarters, from 23.03% in Q1 2022 to 19.22% in Q4 2023. This downward trend indicates a decrease in the company's ability to generate profit from its core operations relative to revenue. Despite fluctuations between quarters, the operating profit margin has generally remained at healthy levels above 17.46% throughout the analyzed period. It is important for the company to monitor this metric closely to ensure operational efficiency and profitability are maintained over time.
Peer comparison
Dec 31, 2023
Company name
Symbol
Operating profit margin
LeMaitre Vascular Inc
LMAT
12.66%
3M Company
MMM
-27.93%
Artivion Inc
AORT
1.73%
Baxter International Inc
BAX
3.00%
Becton Dickinson and Company
BDX
10.08%
Boston Scientific Corp
BSX
16.77%
DexCom Inc
DXCM
16.59%
Embecta Corp
EMBC
15.96%
Glaukos Corp
GKOS
-42.44%
Globus Medical
GMED
8.49%
Haemonetics Corporation
HAE
6.35%